N/A N=48 Isometric Core Muscle Endurance in Healthy Active and Non-active Working Age Populations
Physical Endurance
Primary: Core Muscle Endurance — 530.5 seconds
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=8 Mild Cognitive Impairment and Endurance Exercise in Parkinson's Disease
Parkinson Disease · Mild Cognitive Impairment
Primary: Mean Change in Cognitive Function — -0.6960; -0.6095; 0.6018; 0.6018 z-score
Phase 4 N=8 Impact of Erythropoietin on Hematological Adaptations and Physical Performance
Exercise-Induced Anemia · Physical Performance
Primary: Concentration of Hemoglobin — 1.46 g/dL
N/A N=300 Brief Physical Activity Program to Increase Physical Fitness in Elementary School Children
Childhood Obesity
Primary: Change From Baseline to After Intervention in 75 Foot Laps Completed in 2 Minutes — -0.08; 0.53 Difference in Laps Completed
N/A N=32 Physiologic Adaptations to Interval and Continuous Running at Low Volume and Vigorous Intensity Over 14-Weeks.
Exhaustion - Physiological
Primary: Relative Maximal Oxygen Uptake — 47.8; 50.9; 49.7; 51.7 mL/(kg*min) — p=< 0.05
N/A N=17 A Physical Activity Program in End-state Liver Disease
End-stage Liver Disease (ESLD) · Liver Transplant · Sarcopenia
Primary: Physical Fitness - VO2 — -1; -3 mL oxygen/kg/min — p=0.49
N/A N=722 Swiss Army Physical Fitness Training
Wounds and Injuries · Physical Activity · Mood (Psychological Function)
Primary: Number of Participants With Injuries — 184; 172 participants with injuries
Phase 2 N=39 Evaluation of Cortisol Resistance in Young Sedentary and Endurance-Trained Men
Cortisol Resistance · Negative Feedback · ACTH
Primary: Proportion of Suppressors After Dexamethasone — 0; 1 Participants — p=0.4872
N/A N=33 Strength Training and Endurance Exercise for LIFE
HIV
Primary: Aerobic Capacity — 0.15; 0.02 Liters/minute
N/A N=398 Life 2: Improving Fitness and Function in Elders
Aging · Mobility Limitations
Primary: Usual Gait Speed — 1.03; 1.03 meters/second
N/A N=9 Exercise Mode and Acute Bone Resorption
Osteoporosis · Aging
Primary: C-telopeptide of Type I Collagen (CTX) Change — 0.09; 0.08 ng/mL
N/A N=90 Mindfulness, Mental Fatigue, Inhibitory Control and Endurance Performance in Athletes
Mental Fatigue
Primary: Inhibitory Control: Reaction Time — 461.01; 448.68; 444.35; 465.88 millisecond
Phase 4 N=20 Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD
Chronic Obstructive Pulmonary Disease
Primary: Exercise Endurance Time — 490; 333; 472; 362 seconds — p=< 0.05
N/A N=26 Does Endurance Improve With the Use of Passy-Muir Valve for Patients With Tracheostomy?
PMV · Exercise Endurance · Tracheostomy
Primary: Six Minute Walk Test - First Paired Sessions — 413; 387 Feet — p=0.2795
Early Phase 1 N=10 Influence of Edible Marijuana on Endurance Exercise Performance
Endurance Exercise
Primary: Comparison of Blood Lactate Levels During a 24 Minute Graded Standard Exercise Test (50 Watts, 100 Watts, and 150 Watts) to Placebo. — 0.9699; 1.1437; 1.26345; 1.3618…
N/A N=94 Gas Exchange Kinetics and Work Load During Exercise
Methods of Exercise in Children
Primary: Maximum Oxygen Uptake (VO2) Measurements During Exercise — 1.6; 2.8; 3.2; 1.7 L/min
N/A N=53 Mindfulness Training, Mental Fatigue, Endurance Performance and Neurocognitive Functions
Mindfulness Training · Neurocognitive Function · Sports Performance
Primary: Inhibitory Control: Reaction Time — 10.79; 5.47; 4.11; -0.61 millisecond — p=> 0.05
N/A N=36 Evaluation of a Modified Running-specific Prosthetic Foot
Transtibial Amputation
Primary: Metabolic Oxygen Consumption (VO2), Participants With Unilateral Amputation — 1041.1; 1077.4; 1210.9; 1253.5 ml/min — p=.18
N/A N=30 Impact of Nutritional Supplementation on Aerobic Performance and Fatigue
Performance · Fatigue
Primary: Perceived Exertion — 6.7; 7.4 units on a scale
Phase 2 N=103 Polestriding Versus Walking for Subjects With Poor Leg Circulation
Peripheral Arterial Disease
Primary: Length of Exercise Duration on the Treadmill Constant Work Rate Exercise Test — 15.15; 21.40 minutes — p=0.033
N/A N=32 Physical Training and Heart Rate Variability in COPD
Chronic Obstructive Pulmonary Disease (COPD)
Primary: The SD1 Index, a Nonlinear Index of Heart Rate Variability (HRV)That Represents the Parassimpatetic Activity. — 3.7; 2.8; 7.1; 2.5 miliseconds
N/A N=66 Study of the Long-term Effects of Exercise on Heath Indicators in Older People
Hypertension With Complications and Secondary Hypertension · Overweight and Obesity · Lipid Metabolism Disorders
Primary: Cardiovascular Disease Risk Factors — 3; 4; 5; 7 participants
N/A N=43 Improving Resilience and Longevity for Workers Through Exercise
Osteoarthritis, Knee · Osteoarthritis, Hip
Primary: Change in Lower Extremity Functional Scale — 5.3; -1.6 Units on a scale
Phase 3 N=89 The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease
Primary: Exercise Duration Time Assessed by Constant-load Cycle Ergometry at the End of Each Treatment Period — 586; 475 Seconds
N/A N=28 Effects of Shroom Tech Sport Supplementation and Concurrent Training
Body Composition · Performance Measures · Hormone Profiles
Primary: Change in Body Fat as Measured by Bod Pod — 15.5; 16.2; 14.8; 15.3 Percent Body Fat
N/A N=30 Comparing the Effects of Upper and Lower Body Resistance Training on Pain Sensitivity
Healthy
Primary: Lower Body Resistance Exercise — 594.10; 572.54 kilopascals
Phase 3 N=157 Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry II
Pulmonary Disease, Chronic Obstructive
Primary: Adjusted Mean Endurance Time After 6 Weeks — 354.33; 396.31; 391.45 seconds — p=0.0018
Phase 3 N=181 A Study of Exercise Endurance and Lung Hyperinflation in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
Pulmonary Disease, Chronic Obstructive
Primary: Change From Baseline in Exercise Endurance Time (ET) — 129.45; 13.01 Seconds — p=0.0042
N/A N=21 Physical Training and the Incretin Effect
Healthy
Primary: Incretin Effect (the % of Insulin Secreted Due to the Release of the Intestinal Hormones Glucagon Like Peptide-1 (GLP-1 and Glucose-dependent Insulinotropic Peptide…
N/A N=582 Reduction of Risk for Low Back Injury in Theater of Operations
Lower Back Injury
Primary: Isometric Lumbar Extension Muscular Strength at 11 Weeks — 310.2; 282.7 Nm — p=0.001